Determining Line of Therapy from Real‐World Data in Non‐Small Cell Lung Cancer
These rules provide an updated framework to evaluate current treatment patterns, accounting for the increased use of targeted therapies in patients with mNSCLC, and promote standardization of methods for determining LOT from real-world data.
Authors
- Lova Sun (ORCID: https://orcid.org/0000-0002-5015-2964)
- Wei‐Ting Hwang (ORCID: https://orcid.org/0000-0003-2829-2167)
- Connor B. Grady (ORCID: https://orcid.org/0000-0001-8407-846X)
- Kelsey Leigh Miller
- Wade T. Iams (ORCID: https://orcid.org/0000-0003-2109-298X)
- Fangdi Sun (ORCID: https://orcid.org/0000-0002-5917-6209)
- Gabriela Liliana Bravo Montenegro
- Melina E. Marmarelis (ORCID: https://orcid.org/0000-0003-2187-3583)
- Jared Weiss (ORCID: https://orcid.org/0000-0003-2961-4447)
- Amanda Cass
- Amanda Herrmann
- Tejas Patil (ORCID: https://orcid.org/0000-0003-4389-1010)
- Joshua E. Reuss (ORCID: https://orcid.org/0000-0002-6401-9080)
- Stephen V. Liu (ORCID: https://orcid.org/0000-0002-4852-3914)
- Charu Aggarwal (ORCID: https://orcid.org/0000-0002-3181-9460)
- Kristen Ashley Marrone (ORCID: https://orcid.org/0000-0001-5319-824X)
- Vincent K. Lam (ORCID: https://orcid.org/0000-0002-1319-2588)
- Vamsidhar Velcheti (ORCID: https://orcid.org/0000-0002-6589-0759)
- Jorge J. Nieva (ORCID: https://orcid.org/0000-0003-1605-4719)
- Liza Cosca Villaruz (ORCID: https://orcid.org/0000-0001-7456-523X)
- D. Ross Camidge (ORCID: https://orcid.org/0000-0003-3430-3213)
- Jonathan E. Dowell (ORCID: https://orcid.org/0000-0002-0202-9697)
- Geoffrey Liu (ORCID: https://orcid.org/0000-0002-2603-7296)
- Devalben Patel
- William Schwartzman
Institutions
- University of Southern California (US)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Georgetown University (US)
- Johns Hopkins Medicine (US)
- Princess Margaret Cancer Centre (CA)
- UPMC Hillman Cancer Center (US)
- University of Colorado Cancer Center (US)
- UNC Lineberger Comprehensive Cancer Center
- New York University (US)
- University of Pennsylvania (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University Medical Center (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1002/pds.70049
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- LUNGevity Foundation
- AstraZeneca
- Takeda Oncology